EfA technologies develops the RevDx medical device which is the first completely mobile and programmable multi-channel lab.
The first medical test to be released is a complete blood count (CBC) with 5 Diff, HGB and Platelets.
The device includes the state of the art microscopy and machine learning algorithms along side a proprietary disposable medical chip enabling one step sample preparation.
Results are given on the device within 5 Minutes.
Amir Lubashevsky
[email protected]
Hyozma 6, Yokneam Ilit
+972-544-506-334
http://www.efa-technologies.com
Our Representatives
Company Solutions
EfA Technologies develops the RevDx device as a completely mobile and expandable solution that will be used initially in the primary care space. The RevDx will enable the practitioner without investing in space and expertise to make a better and quicker decisions as to the best treatment for the clinical condition (typically fever bearing condition). The initial use case of the CBC that will give results immediately will support an accurate diagnostics without waiting for the results to come back from the lab. By using a mobile device such as that, there will be no need for labeling and or sending the patients to the various labs for drawing too much blood. The blood sample is being prepared on our proprietary medical chip without reagents or mixing before inserting into the device.
The known use cases will be:
- Infectious diseases: Caused by a virus or bacteria? Decide when not to give antibiotics.
- Oncology treatments and specifically chemo treated patients who need to monitor their immune system regularly.
- Test and transmit at home (Home Hospitalization).
- Hemoglobin levels.
- Count and monitor all 5 different WBC's
- Anemia detection and monitoring.
- Pediatricians can use RevDx taking minimal blood quantities (one drop) analyzing the full blood count of the child on the spot.
- RevDx can be used anywhere also in military setups, travel, home visits, ER, bed side at the hospital and outside clinics.
- Veterinary: An additional algorithms to be developed analyzing the blood samples of animals.
- Parasites detection.
- Sickle cell Anemia.
The RevDx device will include an additional channels to further enhance the diagnostic capabilities and additional algorithms analyzing the microscopy images.
The solution also expands into a big data repository of location based microscopy images for management and research.
RevDx includes all modes of bi-directional communication and can be integrated to any EMR of choice.
Looking For
EfA is looking for investors to join our up and coming round A in Q2.
We are also looking to sign a pre-market LOI's with strategic partners such as: Health solution providers, Home care providers, Distributors of medical devices to the primary care, primary care organizations, NGO's, Insurance companies.
We would like to pilot our solution in the US and Europe with leading primary care providers, GP's , HMO's etc.